메뉴 건너뛰기




Volumn 6, Issue 6, 2013, Pages 1236-1244

The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing

Author keywords

Arrhythmias; Cardiac; Death; Defibrillators; Implantable; Sudden

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL DEVICE COMPLICATION; OUT OF HOSPITAL CARDIAC ARREST; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN CARDIAC DEATH; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; EQUIPMENT DESIGN; HEART FAILURE; PATIENT SELECTION; PRIMARY PREVENTION; PROCEDURES; PROSTHESIS IMPLANTATION; CONGESTIVE CARDIOMYOPATHY; HEART ARRHYTHMIA; IMPLANTATION; METHODOLOGY;

EID: 84892148738     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000481     Document Type: Article
Times cited : (41)

References (72)
  • 1
    • 0037176263 scopus 로고    scopus 로고
    • Dual chamber and VVI implantable defibrillator trial investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial
    • Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288:3115-3123.
    • (2002) JAMA. , vol.288 , pp. 3115-3123
    • Wilkoff, B.L.1    Cook, J.R.2    Epstein, A.E.3    Greene, H.L.4    Hallstrom, A.P.5    Hsia, H.6    Kutalek, S.P.7    Sharma, A.8
  • 4
    • 9844224486 scopus 로고    scopus 로고
    • A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
    • The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    • A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med. 1997;337:1576-1583.
    • (1997) N Engl J Med. , vol.337 , pp. 1576-1583
  • 7
    • 0037149716 scopus 로고    scopus 로고
    • Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
    • Multicenter automatic defibrillator implantation trial II investigators
    • Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
    • (2002) N Engl J Med. , vol.346 , pp. 877-883
    • Moss, A.J.1    Zareba, W.2    Hall, W.J.3    Klein, H.4    Wilber, D.J.5    Cannom, D.S.6    Daubert, J.P.7    Higgins, S.L.8    Brown, M.W.9    Andrews, M.L.10
  • 9
    • 34248579318 scopus 로고    scopus 로고
    • Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years
    • Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-2480.
    • (2007) Circulation. , vol.115 , pp. 2474-2480
    • Kleemann, T.1    Becker, T.2    Doenges, K.3    Vater, M.4    Senges, J.5    Schneider, S.6    Saggau, W.7    Weisse, U.8    Seidl, K.9
  • 18
    • 19944413618 scopus 로고    scopus 로고
    • Longterm clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator
    • Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II), Research Group
    • Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD; Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group. Longterm clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004;110:3760-3765.
    • (2004) Circulation. , vol.110 , pp. 3760-3765
    • Moss, A.J.1    Greenberg, H.2    Case, R.B.3    Zareba, W.4    Hall, W.J.5    Brown, M.W.6    Daubert, J.P.7    McNitt, S.8    Andrews, M.L.9    Elkin, A.D.10
  • 20
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CRXL in chronic heart failure: Metoprolol CRXL randomised intervention trial in congestive heart failure (MERIT-HF
    • MERIT-HF Study Group
    • Hjalmarson A; MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001-2007.
    • (1999) Lancet. , vol.353 , pp. 2001-2007
    • Hjalmarson, A.1
  • 21
    • 77957984258 scopus 로고    scopus 로고
    • Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: An extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II
    • Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II
    • Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, Cygankiewicz I, Zareba W; Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: An extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation. 2010;122:1265-1271.
    • (2010) Circulation. , vol.122 , pp. 1265-1271
    • Goldenberg, I.1    Gillespie, J.2    Moss, A.J.3    Hall, W.J.4    Klein, H.5    McNitt, S.6    Brown, M.W.7    Cygankiewicz, I.8    Zareba, W.9
  • 23
    • 84861639037 scopus 로고    scopus 로고
    • Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator
    • Barsheshet A, Moss AJ, Huang DT, McNitt S, Zareba W, Goldenberg I. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator. J Am Coll Cardiol. 2012;59:2075-2079.
    • (2012) J Am Coll Cardiol. , vol.59 , pp. 2075-2079
    • Barsheshet, A.1    Moss, A.J.2    Huang, D.T.3    McNitt, S.4    Zareba, W.5    Goldenberg, I.6
  • 25
    • 79851476269 scopus 로고    scopus 로고
    • Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death
    • Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011;57:821-828.
    • (2011) J Am Coll Cardiol. , vol.57 , pp. 821-828
    • Iles, L.1    Pfluger, H.2    Lefkovits, L.3    Butler, M.J.4    Kistler, P.M.5    Kaye, D.M.6    Taylor, A.J.7
  • 28
    • 57149125829 scopus 로고    scopus 로고
    • Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: Primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy
    • Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: Primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation. 2008;118:2022-2028.
    • (2008) Circulation. , vol.118 , pp. 2022-2028
    • Gold, M.R.1    Ip, J.H.2    Costantini, O.3    Poole, J.E.4    McNulty, S.5    Mark, D.B.6    Lee, K.L.7    Bardy, G.H.8
  • 33
    • 33644870367 scopus 로고    scopus 로고
    • Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    • Defibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
    • E llenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation. 2006;113:776-782.
    • (2006) Circulation. , vol.113 , pp. 776-782
    • Ellenbogen, K.A.1    Levine, J.H.2    Berger, R.D.3    Daubert, J.P.4    Winters, S.L.5    Greenstein, E.6    Shalaby, A.7    Schaechter, A.8    Subacius, H.9    Kadish, A.10
  • 34
    • 0027190333 scopus 로고
    • A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion
    • Bardy GH, Poole JE, Kudenchuk PJ, Dolack GL, Kelso D, Mitchell R. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion. Circulation. 1993;87:1889-1896.
    • (1993) Circulation. , vol.87 , pp. 1889-1896
    • Bardy, G.H.1    Poole, J.E.2    Kudenchuk, P.J.3    Dolack, G.L.4    Kelso, D.5    Mitchell, R.6
  • 36
    • 20444492445 scopus 로고    scopus 로고
    • Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the pacing fast VT REduces shock therapies (PainFREE Rx II) trial
    • Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation. 2005;111:2898-2905.
    • (2005) Circulation. , vol.111 , pp. 2898-2905
    • Sweeney, M.O.1    Wathen, M.S.2    Volosin, K.3    Abdalla, I.4    DeGroot, P.J.5    Otterness, M.F.6    Stark, A.J.7
  • 37
    • 0035859949 scopus 로고    scopus 로고
    • Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease
    • PainFREE Investigators
    • Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO; PainFREE Investigators. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. 2001;104:796-801.
    • (2001) Circulation. , vol.104 , pp. 796-801
    • Wathen, M.S.1    Sweeney, M.O.2    DeGroot, P.J.3    Stark, A.J.4    Koehler, J.L.5    Chisner, M.B.6    Machado, C.7    Adkisson, W.O.8
  • 38
    • 0037638884 scopus 로고    scopus 로고
    • Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial
    • Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators
    • Y oung JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA. 2003;289:2685-2694.
    • (2003) JAMA. , vol.289 , pp. 2685-2694
    • Young, J.B.1    Abraham, W.T.2    Smith, A.L.3    Leon, A.R.4    Lieberman, R.5    Wilkoff, B.6    Canby, R.C.7    Schroeder, J.S.8    Liem, L.B.9    Hall, S.10    Wheelan, K.11
  • 39
    • 48449088263 scopus 로고    scopus 로고
    • Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study
    • PREPARE Study Investigators
    • Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK; PREPARE Study Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52:541-550.
    • (2008) J Am Coll Cardiol. , vol.52 , pp. 541-550
    • Wilkoff, B.L.1    Williamson, B.D.2    Stern, R.S.3    Moore, S.L.4    Lu, F.5    Lee, S.W.6    Birgersdotter-Green, U.M.7    Wathen, M.S.8    Van Gelder, I.C.9    Heubner, B.M.10    Brown, M.L.11    Holloman, K.K.12
  • 45
    • 33646254610 scopus 로고    scopus 로고
    • Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program
    • CHARM Investigators
    • O lsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA; CHARM Investigators. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006;47:1997-2004.
    • (2006) J Am Coll Cardiol. , vol.47 , pp. 1997-2004
    • Olsson, L.G.1    Swedberg, K.2    Ducharme, A.3    Granger, C.B.4    Michelson, E.L.5    McMurray, J.J.6    Puu, M.7    Yusuf, S.8    Pfeffer, M.A.9
  • 48
    • 84870404695 scopus 로고    scopus 로고
    • Implantable cardioverter-defibrillator shock prevention does not reduce mortality: A systemic review
    • Ha AH, Ham I, Nair GM, Connolly SJ, Dorian P, Morillo CA, Healey JS. Implantable cardioverter-defibrillator shock prevention does not reduce mortality: A systemic review. Heart Rhythm. 2012;9:2068-2074.
    • (2012) Heart Rhythm. , vol.9 , pp. 2068-2074
    • Ha, A.H.1    Ham, I.2    Nair, G.M.3    Connolly, S.J.4    Dorian, P.5    Morillo, C.A.6    Healey, J.S.7
  • 49
    • 84857553763 scopus 로고    scopus 로고
    • Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID going head to head trial
    • Gold MR, Ahmad S, Browne K, Berg KC, Thackeray L, Berger RD. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm. 2012;9:370-377.
    • (2012) Heart Rhythm. , vol.9 , pp. 370-377
    • Gold, M.R.1    Ahmad, S.2    Browne, K.3    Berg, K.C.4    Thackeray, L.5    Berger, R.D.6
  • 51
    • 84892155262 scopus 로고    scopus 로고
    • Inappropriate shock outcomes for subjects programmed to single vs dual zone configuration with the subcutaneous implantable defibrillator
    • Gold MR, Weiss R, Smith W, Leon A, Knight B, Carter N, Husby M, Burke MC. Inappropriate shock outcomes for subjects programmed to single vs dual zone configuration with the subcutaneous implantable defibrillator. Heart Rhythm. 2013;10:S59-S60.
    • (2013) Heart Rhythm. , vol.10
    • Gold, M.R.1    Weiss, R.2    Smith, W.3    Leon, A.4    Knight, B.5    Carter, N.6    Husby, M.7    Burke, M.C.8
  • 52
    • 79957527936 scopus 로고    scopus 로고
    • Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter- defibrillator implantation
    • Haines DE, Wang Y, Curtis J. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation. Circulation. 2011;123:2069-2076.
    • (2011) Circulation. , vol.123 , pp. 2069-2076
    • Haines, D.E.1    Wang, Y.2    Curtis, J.3
  • 54
    • 79952113281 scopus 로고    scopus 로고
    • Acute lead dislodgements and inhospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry
    • Cheng A, Wang Y, Curtis JP, Varosy PD. Acute lead dislodgements and inhospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. J Am Coll Cardiol. 2010;56:1651-1656.
    • (2010) J Am Coll Cardiol. , vol.56 , pp. 1651-1656
    • Cheng, A.1    Wang, Y.2    Curtis, J.P.3    Varosy, P.D.4
  • 56
    • 33644693959 scopus 로고    scopus 로고
    • Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients
    • Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol. 2005;28:926-932.
    • (2005) Pacing Clin Electrophysiol. , vol.28 , pp. 926-932
    • Alter, P.1    Waldhans, S.2    Plachta, E.3    Moosdorf, R.4    Grimm, W.5
  • 61
    • 64649087022 scopus 로고    scopus 로고
    • Increasing hazard of Sprint Fidelis implantable cardioverter- defibrillator lead failure
    • Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2009;6:605-610.
    • (2009) Heart Rhythm. , vol.6 , pp. 605-610
    • Hauser, R.G.1    Hayes, D.L.2
  • 62
    • 84892178989 scopus 로고    scopus 로고
    • Accessed August 20 2013
    • http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm314930. htm. Accessed August 20, 2013.
  • 63
    • 84864423015 scopus 로고    scopus 로고
    • Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads
    • Hauser RG, Abdelhadi R, McGriff D, Retel LK. Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm. 2012;9:1227-1235.
    • (2012) Heart Rhythm. , vol.9 , pp. 1227-1235
    • Hauser, R.G.1    Abdelhadi, R.2    McGriff, D.3    Retel, L.K.4
  • 67
    • 58549089344 scopus 로고    scopus 로고
    • Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: Data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry
    • Get With The Guidelines Steering Committee
    • Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED; Get With The Guidelines Steering Committee. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: Data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. J Am Coll Cardiol. 2009;53:416-422.
    • (2009) J Am Coll Cardiol. , vol.53 , pp. 416-422
    • Shah, B.1    Hernandez, A.F.2    Liang, L.3    Al-Khatib, S.M.4    Yancy, C.W.5    Fonarow, G.C.6    Peterson, E.D.7
  • 69
    • 84861317733 scopus 로고    scopus 로고
    • Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: A national survey
    • Castellanos JM, Smith LM, Varosy PD, Dehlendorf C, Marcus GM. Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: A national survey. Heart Rhythm. 2012;9:874-881.
    • (2012) Heart Rhythm. , vol.9 , pp. 874-881
    • Castellanos, J.M.1    Smith, L.M.2    Varosy, P.D.3    Dehlendorf, C.4    Marcus, G.M.5
  • 71
    • 30444439243 scopus 로고    scopus 로고
    • Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial
    • Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators
    • Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH; Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC Study: A randomized trial. JAMA. 2006;295:165-171.
    • (2006) JAMA. , vol.295 , pp. 165-171
    • Connolly, S.J.1    Dorian, P.2    Roberts, R.S.3    Gent, M.4    Bailin, S.5    Fain, E.S.6    Thorpe, K.7    Champagne, J.8    Talajic, M.9    Coutu, B.10    Gronefeld, G.C.11    Hohnloser, S.H.12
  • 72
    • 84863654279 scopus 로고    scopus 로고
    • Subcutaneous implantable cardioverter defibrillator
    • Rowley CP, Gold MR. Subcutaneous implantable cardioverter defibrillator. Circ Arrhythm Electrophysiol. 2012;5:587-593.
    • (2012) Circ Arrhythm Electrophysiol. , vol.5 , pp. 587-593
    • Rowley, C.P.1    Gold, M.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.